Search Results - "Resar, Linda Ms"

Refine Results
  1. 1

    HMGA1 drives stem cell, inflammatory pathway, and cell cycle progression genes during lymphoid tumorigenesis by Schuldenfrei, Andrew, Belton, Amy, Kowalski, Jeanne, Talbot, Jr, C Conover, Di Cello, Francescopaolo, Poh, Weijie, Tsai, Hua-Ling, Shah, Sandeep N, Huso, Tait H, Huso, David L, Resar, Linda M S

    Published in BMC genomics (04-11-2011)
    “…Although the high mobility group A1 (HMGA1) gene is widely overexpressed in diverse cancers and portends a poor prognosis in some tumors, the molecular…”
    Get full text
    Journal Article
  2. 2

    Dominant-negative c-Jun (TAM67) target genes: HMGA1 is required for tumor promoter-induced transformation by DHAR, Arindam, JING HU, REEVES, Raymond, RESAR, Linda M. S, COLBURN, Nancy H

    Published in Oncogene (27-05-2004)
    “…Activation of the transcription factor AP-1 (activator protein-1) is required for tumor promotion and maintenance of malignant phenotype. A number of…”
    Get full text
    Journal Article
  3. 3

    Efficient human iPS cell derivation by a non-integrating plasmid from blood cells with unique epigenetic and gene expression signatures by Chou, Bin-Kuan, Mali, Prashant, Huang, Xiaosong, Ye, Zhaohui, Dowey, Sarah N, Resar, Linda MS, Zou, Chunlin, Zhang, Y Alex, Tong, Jay, Cheng, Linzhao

    Published in Cell research (01-03-2011)
    “…To identify accessible and permissive human cell types for efficient derivation of induced pluripotent stem cells (iPSCs), we investigated epigenetic and gene…”
    Get full text
    Journal Article
  4. 4

    Use of pegylated interferon in young patients with polycythemia vera and essential thrombocythemia by Kucine, Nicole, Bergmann, Shayla, Krichevsky, Spencer, Jones, Devin, Rytting, Michael, Jain, Juhi, Bennett, Carolyn M., Resar, Linda M.S., Mascarenhas, John, Verstovsek, Srdan, Hoffman, Ronald

    Published in Pediatric blood & cancer (01-03-2021)
    “…Myeloproliferative neoplasms (MPN) are rare disorders in young patients, and because of this, standardized treatment recommendations are not available…”
    Get full text
    Journal Article
  5. 5

    Doubling up on function: dual-specificity tyrosine-regulated kinase 1A (DYRK1A) in B cell acute lymphoblastic leukemia by Kim, Jung-Hyun, Li, Liping, Resar, Linda Ms

    Published in The Journal of clinical investigation (04-01-2021)
    “…DYRK1A, the dual-specificity kinase, is again doubling up on function, as reported by Bhansali, Rammohan, and colleagues in this issue of the JCI. DYRK1A is an…”
    Get full text
    Journal Article
  6. 6

    Taking the STING out of acute myeloid leukemia through macrophage-mediated phagocytosis by Dalton, William Brian, Ghiaur, Gabriel, Resar, Linda Ms

    Published in The Journal of clinical investigation (01-03-2022)
    “…Macrophages within the bone marrow (BM) microenvironment take on unexpected roles in acute myeloid leukemia (AML) as reported by Moore and colleagues in this…”
    Get full text
    Journal Article
  7. 7
  8. 8

    A novel method of data analysis for utilization of red blood cell transfusion by Frank, Steven M., Resar, Linda M.S., Rothschild, James A., Dackiw, Elizabeth A., Savage, Will J., Ness, Paul M.

    Published in Transfusion (Philadelphia, Pa.) (01-12-2013)
    “…Background A necessary component of an effective blood management program is the accurate and comprehensive collection and analysis of blood utilization data…”
    Get full text
    Journal Article
  9. 9

    Abstract 1704: High mobility group A1 chromatin remodeling protein expands the intestinal stem cell compartment and Paneth cell niche through Wnt-catenin signaling and Sox9 by Xian, Lingling, Huso, Tait, Belton, Amy, Huso, David, Resar., Linda MS

    Published in Cancer research (Chicago, Ill.) (15-07-2016)
    “…The High Mobility Group A1 (HMGA1) gene is overexpressed in most poorly differentiated cancers and high levels portend adverse clinical outcomes, although the…”
    Get full text
    Journal Article
  10. 10

    Efficacy of education followed by computerized provider order entry with clinician decision support to reduce red blood cell utilization by Zuckerberg, Gabriel S., Scott, Andrew V., Wasey, Jack O., Wick, Elizabeth C., Pawlik, Timothy M., Ness, Paul M., Patel, Nishant D., Resar, Linda M.S., Frank, Steven M.

    Published in Transfusion (Philadelphia, Pa.) (01-07-2015)
    “…BACKGROUND Two necessary components of a patient blood management program are education regarding evidence‐based transfusion guidelines and computerized…”
    Get full text
    Journal Article
  11. 11

    Bloodless medicine: current strategies and emerging treatment paradigms by Resar, Linda M.S., Wick, Elizabeth C., Almasri, Talal Nael, Dackiw, Elizabeth A., Ness, Paul M., Frank, Steven M.

    Published in Transfusion (Philadelphia, Pa.) (01-10-2016)
    “…BACKGROUND Advances in our understanding of the risks associated with allogeneic blood transfusions (ABTs) and the growing number of patients who wish to avoid…”
    Get full text
    Journal Article
  12. 12

    Characterizing metabolic changes in human colorectal cancer by Williams, Michael D., Zhang, Xing, Park, Jeong-Jin, Siems, William F., Gang, David R., Resar, Linda M. S., Reeves, Raymond, Hill, Herbert H.

    Published in Analytical and bioanalytical chemistry (01-06-2015)
    “…Colorectal cancer (CRC) remains a leading cause of cancer death worldwide, despite the fact that it is a curable disease when diagnosed early. The development…”
    Get full text
    Journal Article
  13. 13

    Equity and diversity in academic medicine: a perspective from the JCI editors by Resar, Linda Ms, Jaffee, Elizabeth M, Armanios, Mary, Jackson, Sarah, Azad, Nilofer S, Horton, Maureen R, Kaplan, Mariana J, Laiho, Marikki, Maus, Marcela V, Sumner, Charlotte J, Wheelan, Sarah J, Wills-Karp, Marsha

    Published in The Journal of clinical investigation (01-10-2019)
    “…The #MeToo movement has taken on sexual harassment in the workplace and served to inform the world that these unacceptable and illegal acts have become…”
    Get full text
    Journal Article
  14. 14

    The high mobility group A1 molecular switch: turning on cancer - can we turn it off? by Huso, Tait H, Resar, Linda M S

    Published in Expert opinion on therapeutic targets (01-05-2014)
    “…Emerging evidence demonstrates that the high mobility group A1 (HMGA1) chromatin remodeling protein is a key molecular switch required by cancer cells for…”
    Get more information
    Journal Article
  15. 15

    HMGA2 Participates in Transformation in Human Lung Cancer by Di Cello, Francescopaolo, Hillion, Joelle, Hristov, Alexandra, Wood, Lisa J, Mukherjee, Mita, Schuldenfrei, Andrew, Kowalski, Jeanne, Bhattacharya, Raka, Ashfaq, Raheela, Resar, Linda M S

    Published in Molecular cancer research (01-05-2008)
    “…Although previous studies have established a prominent role for HMGA1 (formerly HMG-I/Y ) in aggressive human cancers, the role of HMGA2 (formerly HMGI-C ) in…”
    Get full text
    Journal Article
  16. 16
  17. 17

    HMGA1 correlates with advanced tumor grade and decreased survival in pancreatic ductal adenocarcinoma by Hristov, Alexandra C, Cope, Leslie, Di Cello, Francescopaolo, Reyes, Marcelo Delos, Singh, Mansher, Hillion, Joelle A, Belton, Amy, Joseph, Biju, Schuldenfrei, Andrew, Iacobuzio-Donahue, Christine A, Maitra, Anirban, Resar, Linda MS

    Published in Modern pathology (01-01-2010)
    “…Although pancreatic ductal adenocarcinoma is a common and almost uniformly fatal cancer, little is known about the molecular events that lead to tumor…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    AKNA: Another AT-hook transcription factor "hooking-up" with inflammation by Moliterno, Alison R, Resar, Linda MS

    Published in Cell research (01-11-2011)
    “…Previous studies highlight a key role for AT-hook transcription factors as master regulators of fundamental cellu- lar processes involved in development,…”
    Get full text
    Journal Article